Volume 3: Issue 2

The scientific program of the Pulmonary Hypertension Association is guided by the association's Scientific Leadership Council. The Council includes the following health care professionals:

Michael McGoon, MD, SLC Chair, Pulmonary Hypertension Clinic/Mayo Clinic, Rochester, MN
Robyn Barst, MD, SLC Vice-Chair, Columbia Presbyterian Medical Center, Babies Hospital, New York, Ny
David B. Badesch, MD, Chair, Nominations Committeee, University of Colorado Health Sciences, Denver, CO
Ray Benza, MD, University of Alabama, Birmingham, AL
Richard Channick, MD, UCSD Medical Center, La Jolla, CA
C. Gregory Elliott, MD, LDS Hospital, University of Utah School of Medicine, Salt Lake

For the first time in its history the Pulmonary Hypertension Association's international conference will include a scientific program for physicians, researchers, and nurses. Featuring internationally known experts, the scientific program is entitled, From Puzzle to Picture—Mechanisms of PH: Identification of the Next Therapeutic Targets, June 24–25 in Miami, Florida.

Co-sponsored by the National Heart, Lung, and Blood Institute (NIH), the Centers for Disease Control and Prevention (CDC) and the Office of Rare Diseases (ORD), the program will include poster sessions, abstracts, and workshops as it consolidates recent basic and investigational advances to develop a consensus structure for further

This discussion was moderated by Ronald J. Oudiz, MD, Associate Professor of Medicine, David Geffen School of Medicine at UCLA, and Director, Liu Center for Pulmonary Hypertension, Division of Cardiology, Harbor-UCLA Medical Center, Torrance, California. The participants included Michael J. Krowka, MD, Professor of Medicine, and Russell Wiesner, MD, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, and Michael Ramsay, MD, FRCA, Chairman, Department of Anesthesiology and Pain Management, Baylor University Medical Center, and Clinical Professor, Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, Texas.

The Scientific Leadership Council of the Pulmonary Hypertension Association

Making History in Miami at PHA's 6^th International Conference

Michael D. McGoon, MD: Guiding Light for PHA Scientific Leadership Council and Proponent of New Research

Portopulmonary Hypertension: Understanding Pulmonary Hypertension in the Setting of Liver Disease

Introduction

Liver Transplant Considerations and Outcomes for the Portopulmonary Hypertension Patient

Exploring the Spectrum of Pathology and Treatment in Portopulmonary Hypertension: Four Experts Address the Toughest Questions

Conference Abstracts

Guest Editor’s Memo

A Roundtable Discussion Addressing Patient-Centered Care and Quality of Life in Patients With Pulmonary Arterial Hypertension

Editor’s Memo

Pulmonary Hypertension Associated With Parenchymal Lung Disease